Virtual Galaxy Infotech Fund Raise of ₹19.77 Cr

Virtual Galaxy Infotech Other Announcement

Virtual Galaxy Infotech filed non-applicability of corporate governance (SME exemption) and a zero-complaint Reg 13(3) grievance statement for Q1 FY27. No transaction or business event is reported.

Virtual Galaxy Infotech Management Change

Virtual Galaxy Infotech Limited has appointed Mr. Sunil Kulkarni as a Non-Executive Director. His appointment was regularized at the company's 29th Annual General Meeting.

Virtual Galaxy Infotech Annual General Meeting

Virtual Galaxy Infotech Limited held its 29th Annual General Meeting on September 24, 2026. The company submitted the proceedings of this meeting to the exchange.

Virtual Galaxy Infotech Annual General Meeting

Virtual Galaxy Infotech issued a corrigendum to its 29th AGM notice, adding disclosures for Item No. 4 (Related Party Transactions) and Item No. 6 (IPO objects).

Virtual Galaxy Infotech Annual General Meeting

Virtual Galaxy Infotech Limited has issued a notice for its 29th Annual General Meeting scheduled for September 24, 2026. The meeting will address standard business items.

Virtual Galaxy Infotech Management Change

Virtual Galaxy Infotech has appointed Mr. Sunil Kulkarni as an Additional Non-Executive Director. His fintech experience will support the company's payment aggregator and PPI business initiatives.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr